{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:51:09Z","timestamp":1753876269862,"version":"3.41.2"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Acute and subacute stent thromboses are a rare complication associated with high mortality and morbidity occurring in \u223c1.5% of patients treated with primary percutaneous intervention for ST-elevation myocardial infarction (STEMI). Recent publications describe a potential role of the von Willebrand factor (VWF) in thrombus formation at sites of critical coronary stenosis in STEMI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case summary<\/jats:title><jats:p>We describe a 58-year-old woman with STEMI at initial presentation, who suffered subacute stent thrombosis despite good stent expansion, efficacious dual antiplatelet therapy, and therapeutic anticoagulation. Because of very high VWF values, we administered N-acetylcysteine in order to depolymerize VWF, but the drug was not well tolerated. Since the patient was still symptomatic, we used caplacizumab in order to prevent VWF from interacting with platelets. Under this treatment, the clinical and angiographic course was favourable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Considering a modern view of intracoronary thrombus pathophysiology, we describe an innovative treatment approach, which eventually ended in a favourable outcome.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ehjcr\/ytac497","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T08:32:12Z","timestamp":1674030732000},"source":"Crossref","is-referenced-by-count":2,"title":["Caplacizumab for treating subacute intra-stent thrombus occurring despite efficacious double anti-platelet treatment and anticoagulation: a case report"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0536-5418","authenticated-orcid":false,"given":"Gregoire","family":"Stalder","sequence":"first","affiliation":[{"name":"Service and Central Laboratory of Hematology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL) , rue du Bugnon 46, CH-1011 Lausanne , Switzerland"},{"name":"Service of Hematology and Laboratory of Hematology, Institut Central des H\u00f4pitaux, H\u00f4pital du Valais , Av. du Grand-Champsec 86, CH-1951 Sion , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Chatte","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL) , rue du Bugnon 46, CH-1011 Lausanne , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemy","family":"De Rossi","sequence":"additional","affiliation":[{"name":"Service and Central Laboratory of Hematology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL) , rue du Bugnon 46, CH-1011 Lausanne , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Yerly","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL) , rue du Bugnon 46, CH-1011 Lausanne , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9686-9920","authenticated-orcid":false,"given":"Lorenzo","family":"Alberio","sequence":"additional","affiliation":[{"name":"Service and Central Laboratory of Hematology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL) , rue du Bugnon 46, CH-1011 Lausanne , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Eeckhout","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL) , rue du Bugnon 46, CH-1011 Lausanne , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ijcard.2012.01.080","article-title":"Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses","volume":"167","author":"D'Ascenzo","year":"2013","journal-title":"Int J Cardiol"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41569-018-0118-5","article-title":"Predictors of stent thrombosis and their implications for clinical practice","volume":"16","author":"Gori","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12265-012-9422-3","article-title":"von Willebrand factor inhibition improves endothelial function in patients with stable angina","volume":"6","author":"Muller","year":"2013","journal-title":"J Cardiovasc Transl Res"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/2048872615585518","article-title":"Kinetics of high-sensitivity cardiac troponin T and I differ in patients with ST-segment elevation myocardial infarction treated by primary coronary intervention","volume":"5","author":"Laugaudin","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017393","article-title":"Temporal evolution of Serum concentrations of high-sensitivity cardiac troponin during 1 year after acute coronary syndrome admission","volume":"10","author":"Van den Berg","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.thromres.2013.10.008","article-title":"Evaluation of laboratory methods routinely used to detect the effect of aspirin against new reference methods","volume":"133","author":"Kov\u00e1cs","year":"2014","journal-title":"Thromb Res"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1172\/JCI41062","article-title":"N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice","volume":"121","author":"Chen","year":"2011","journal-title":"J Clin Invest"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCULATIONAHA.117.027290","article-title":"Potent thrombolytic effect of N-acetylcysteine on arterial thrombi","volume":"136","author":"Martinez de Lizarrondo","year":"2017","journal-title":"Circulation"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"key":"2023030116251493700_","article-title":"A pilot study of N-acetylcysteine in thrombotic thrombocytopenia Purpura"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12265-012-9435-y","article-title":"Novel antiplatelet agents: ALX-0081, a nanobody directed towards von Willebrand factor","volume":"6","author":"Bartunek","year":"2013","journal-title":"J Cardiovasc Transl Res"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/jcp.25887","article-title":"A biophysical view on von Willebrand factor activation","volume":"233","author":"L\u00f6f","year":"2018","journal-title":"J Cell Physiol"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"7858","DOI":"10.1038\/ncomms8858","article-title":"Flow-driven assembly of VWF fibres and webs in in vitro microvessels","volume":"6","author":"Zheng","year":"2015","journal-title":"Nat Commun"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood-2015-12-688010","article-title":"Acquired intracoronary ADAMTS13 deficiency and VWF retention at sites of critical coronary stenosis in patients with STEMI","volume":"127","author":"Pedrazzini","year":"2016","journal-title":"Blood"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/bloodadvances.2020003135","article-title":"Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism","volume":"5","author":"Edvardsen","year":"2021","journal-title":"Blood Adv"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1613747","article-title":"High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism","volume":"83","author":"Kraaijenhagen","year":"2000","journal-title":"Thromb Haemost"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/heartjnl-2020-318872","article-title":"Ticagrelor versus prasugrel for PCI-managed myocardial infarction: the battle of the giants continues","volume":"107","author":"Storey","year":"2021","journal-title":"Heart"},{"key":"2023030116251493700_","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","article-title":"Ticagrelor or prasugrel in patients with acute coronary syndromes","volume":"381","author":"Sch\u00fcpke","year":"2019","journal-title":"N Engl J Med"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytac497\/48754402\/ytac497.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/7\/2\/ytac497\/49168327\/ytac497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/7\/2\/ytac497\/49168327\/ytac497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T10:17:39Z","timestamp":1679393859000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytac497\/6990880"}},"subtitle":[],"editor":[{"given":"Dimitrios A","family":"Vrachatis","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Felice","family":"Gragnano","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Adam","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Milenko Zoran","family":"Cankovic","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Spinthakis","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Michael","family":"Waight","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytac497","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2023,1,18]]},"article-number":"ytac497"}}